{
    "eid": "2-s2.0-85048165592",
    "title": "Development of ultra-short PCR assay to reveal BRAF V600 mutation status in Thai colorectal cancer tissues",
    "cover-date": "2018-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Biochemistry, Genetics and Molecular Biology (all)",
            "@code": "1300",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Agricultural and Biological Sciences (all)",
            "@code": "1100",
            "@abbrev": "AGRI"
        },
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [],
    "authors": [
        "Nunthawut Chat-Uthai",
        "Pichpisith Vejvisithsakul",
        "Sutthirat Udommethaporn",
        "Puttarakun Meesiri",
        "Chetiya Danthanawanit",
        "Yannawan Wongchai",
        "Chinachote Teerapakpinyo",
        "Shanop Shuangshoti",
        "Naravat Poungvarin"
    ],
    "citedby-count": 8,
    "ref-count": 61,
    "ref-list": [
        "Mutations of the BRAF gene in human cancer",
        "BRAFV600E: Implications for carcinogenesis and molecular therapy",
        "Multisite analytic performance studies of a real-time polymerase chain reaction assay for the detection of BRAF V600E mutations in formalin-fixed, paraffin-embedded tissue specimens of malignant melanoma",
        "Non-p.V600E BRAF Mutations Are Common Using a More Sensitive and Broad Detection Tool",
        "Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes",
        "Predictive and prognostic roles of BRAF mutation in stage III colon cancer: Results from intergroup trial CALGB 89803",
        "Dietary, lifestyle and clinicopathological factors associated with BRAF and K-ras mutations arising in distinct subsets of colorectal cancers in the EPIC Norfolk study",
        "Characteristics and prevalence of KRAS, BRAF, and PIK3CA mutations in colorectal cancer by high-resolution melting analysis in Taiwanese population",
        "Clinical meaning of BRAF mutation in Korean patients with advanced colorectal cancer",
        "Elucidating the prognostic significance of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese patients with metastatic colorectal cancer",
        "Prognostic relevance of KRAS and BRAF mutations in Japanese patients with colorectal cancer",
        "Colorectal cancers from distinct ancestral populations show variations in BRAF mutation frequency",
        "Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): Updated efficacy results from a randomised, double-blind, phase 3 trial",
        "Cobimetinib Plus Vemurafenib: A Review in BRAF (V600) Mutation-Positive Unresectable or Metastatic Melanoma",
        "Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): Extended follow-up of a phase 3, randomised, open-label study",
        "Long Term Survival and Continued Complete Response of Vemurafenib in a Metastatic Melanoma Patient with BRAF V600K Mutation",
        "Dabrafenib: First global approval",
        "Trametinib: First global approval",
        "Cobimetinib: First Global Approval",
        "Dabrafenib in patients with BRAF (V600E)-positive advanced non-small-cell lung cancer: A single-arm, multicentre, open-label, phase 2 trial",
        "A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib",
        "Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer",
        "Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations",
        "A multisite blinded study for the detection of BRAF mutations in formalin-fixed, paraffin-embedded malignant melanoma",
        "Detection of BRAF(V600E) Mutations in Papillary Thyroid Carcinomas by Peptide Nucleic Acid Clamp Real-Time PCR: A Comparison with Direct Sequencing",
        "Real-time allele-specific amplification for sensitive detection of the BRAF mutation V600E",
        "PCR analysis in archival postmortem tissues",
        "Purification of DNA from formaldehyde fixed and paraffin embedded human tissue",
        "Multiplex picoliter-droplet digital PCR for quantitative assessment of DNA integrity in clinical samples",
        "Sequence artifacts in DNA from formalin-fixed tissues: Causes and strategies for minimization",
        "Melanin binds reversibly to thermostable DNA polymerase and inhibits its activity",
        "Highly sensitive EGFR mutation detection by specific amplification of mutant alleles",
        "Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936",
        "The elimination of primer-dimer accumulation in PCR",
        "A homogeneous fluorescence assay for PCR amplicons: Its application to real-time, single-tube genotyping",
        "High-throughput oncogene mutation profiling in human cancer",
        "Evaluation of high-resolution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumors",
        "CfDNA analysis from blood in melanoma",
        "BRAF mutation analysis in circulating free tumor DNA of melanoma patients treated with BRAF inhibitors",
        "Allele specific Taqman-based real-time PCR assay to quantify circulating BRAFV600E mutated DNA in plasma of melanoma patients",
        "Evaluation of BRAF mutation testing methodologies in formalin-fixed, paraffin-embedded cutaneous melanomas",
        "Comparison of testing methods for the detection of BRAF V600E mutations in malignant melanoma: Pre-approval validation study of the companion diagnostic test for vemurafenib",
        "Analytical performance of a real-time PCR-based assay for V600 mutations in the BRAF gene, used as the companion diagnostic test for the novel BRAF inhibitor vemurafenib in metastatic melanoma",
        "Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases",
        "BRAF V600E mutation-specific antibody: A review",
        "Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody",
        "Advantages of immu-nostaining over DNA analysis using PCR amplification to detect p53 abnormality in long-term formalin-fixed tissues of human colorectal carcinomas",
        "VE1 antibody is not highly specific for the BRAF V600E mutation in thyroid cytology categories with the exception of malignant cases",
        "Cross-reactivity of the BRAF VE1 antibody with epitopes in axonemal dyneins leads to staining of cilia",
        "Usefulness of immunocyto-chemistry for the detection of the BRAF(V600E) mutation in circulating tumor cells from metastatic melanoma patients",
        "Rare BRAF mutations in melanoma patients: Implications for molecular testing in clinical practice",
        "Detection of BRAF V600E mutations in skin metastases of malignant melanoma by monoclonal antibody VE1",
        "The isolation of nucleic acids from fixed, paraffin-embedded tissues-which methods are useful when?",
        "Somatic Mutations of K-Ras and BRAF in Thai Colorectal Cancer and their Prognostic Value",
        "Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer",
        "Pyrosequencing analysis of KRAS codon 61 mutations in Thai patients with advanced colorectal cancer",
        "Validation of a Multiplex Allele-Specific Polymerase Chain Reaction Assay for Detection of KRAS Gene Mutations in Formalin-Fixed, Paraffin-Embedded Tissues from Colorectal Cancer Patients",
        "Molecular pathological epidemiology of colorectal neo-plasia: An emerging transdisciplinary and interdisciplinary field",
        "Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine",
        "Lifetime alcohol intake is associated with an increased risk of KRAS+ and BRAF-/KRAS- But not BRAF+ colorectal cancer",
        "Molecular pathological epidemiology of colorectal cancer in Chinese patients with KRAS and BRAF mutations"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60011189",
            "affilname": "Faculty of Medicine Siriraj Hospital, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011189",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Department of Medicine",
        "City",
        "Health Systems Institute",
        "Mahidol University",
        "National Research Council of Thailand",
        "Health Systems Research Institute"
    ]
}